InsidersTradesSigma
Discover the complete record of transactions filed by Blaustein Marc, Chief Operating Officer. Insider active across 1 company, notably Finch Therapeutics Group, Inc.. Cumulatively, 1 disclosures have been logged. Activity tracked since 13 June 2022. The latest transaction was filed on 13 June 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Marc Blaustein is the Chief Operating Officer at Finch Therapeutics Group, Inc. He is responsible for managing operations and optimizing processes within the company. His experience in the biopharmaceutical sector is an asset in ensuring efficiency and innovation.